ScholarLens Back to search
2007•Ningxia Medical JournalRequires access

Therapeutic value of bi-level positive airway pressure in chronic obstructive pulmonary disease with respiratory failure type II

Huang Xiao-b

Open publisher page 0 citations

Abstract

Objective To study therapeutic value of bi-level positive airway pressure(BIPAP) ventilation in chronic obstructive pulmonary disease with respiratory failure type Ⅱ.Methods 60 patients were divided into control group(oxygen inhalation by nasal tube combined medication) and treatment group(therapeutic schedule of control group combined BIPAP),and therapeutic effects were compared in two groups.Results Before BIPAP therapy,there was no difference in age,disturbance of consciousness,blood gas analysis and heart rate between two groups.7 days after BIPAP therapy,arterial partial pressure of oxygen ascended and arterial carbon dioxide tension decreased in both groups,but improvement of blood gas analysis in treatment group was better than that in control group.Conclusion BIPAP ventilation is an effective therapy in patients with COPD with respiratory failure type Ⅱ,and it is worthy of clinic application.

About this research paper

What this paper is about

Objective To study therapeutic value of bi-level positive airway pressure(BIPAP) ventilation in chronic obstructive pulmonary disease with respiratory failure type Ⅱ.Methods 60 patients were divided into control group(oxygen inhalation by nasal tube combined medication) and treatment group(therapeutic schedule of control group combined BIPAP),and therapeutic effects were compared in two groups.Results Before BIPAP therapy,there was no difference in age,disturbance of consciousness,blood gas analysis and heart rate between two groups.7 days after BIPAP therapy,arterial partial pressure of oxygen ascended and arterial carbon dioxide tension decreased in both groups,but improvement of blood gas analysis in treatment group was better than that in control group.Conclusion BIPAP ventilation is an effective therapy in patients with COPD with respiratory failure type Ⅱ,and it is worthy of clinic application.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To study therapeutic value of bi-level positive airway pressure(BIPAP) ventilation in chronic obstructive pulmonary disease with respiratory failure type Ⅱ.Methods 60 patients were divided into control group(oxygen inhalation by nasal tube combined medication) and treatment group(therapeutic schedule of control group combined BIPAP),and therapeutic effects were compared in two groups.Results Before BIPAP therapy,there was no difference in age,disturbance of consciousness,blood gas analysis and heart rate between two groups.7 days after BIPAP therapy,arterial partial pressure of oxygen ascended and arterial carbon dioxide tension decreased in both groups,but improvement of blood gas analysis in treatment group was better than that in control group.Conclusion BIPAP ventilation is an effective therapy in patients with COPD with respiratory failure type Ⅱ,and it is worthy of clinic application.

Key concepts: Medicine, Positive airway pressure, Respiratory failure, COPD, Anesthesia, Arterial blood, Ventilation (architecture), Respiratory system

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Therapeutic value of bi-level positive airway pressure in chronic obstructive pulmonary disease with respiratory failure type II — Research Paper | ScholarLens